Three independent discounted-cash-flow-style models value Haemonetics Corporation every trading day. 0 of 3 currently price HAE above its market price.
| Free Cash Flow model | $43.74 |
| Excess Profit model | $11.03 |
| Residual Earnings model | $41.64 |
| Dividend Discount model | — |
| Piotroski F-Score | 9 / 9 |
| Return on invested capital | +6.1% |
| Net debt / EBITDA | 6.3× |
| Gross margin | +59.0% |
| Revenue CAGR | +4.5% |
| Cash conversion | 3.0× |
| Dividend yield | — |
| Buyback yield | +6.3% |
These are StockKitty's default assumptions. In the app, the models recompute live as you adjust growth, discount rates, and margins — and the AI explains the bull case, bear case, and quality picture.
Open HAE in StockKitty